1. Unveiling the anti-inflammatory mechanism of exogenous hydrogen sulfide in Kawasaki disease based on network pharmacology and experimental validation.
- Author
-
Yu L, Luo Q, Rao X, Xiao X, and Wang P
- Subjects
- Animals, Mice, Network Pharmacology, Humans, NF-kappa B metabolism, Sulfides pharmacology, Male, Disease Models, Animal, Cytokines metabolism, Protein Interaction Maps drug effects, Mucocutaneous Lymph Node Syndrome drug therapy, Mucocutaneous Lymph Node Syndrome metabolism, Hydrogen Sulfide pharmacology, Hydrogen Sulfide metabolism, Myeloid Differentiation Factor 88 metabolism, Myeloid Differentiation Factor 88 genetics, Anti-Inflammatory Agents pharmacology, Signal Transduction drug effects, Toll-Like Receptor 4 metabolism
- Abstract
Kawasaki disease (KD) is a severe pediatric vasculitis leading to coronary artery complications. Hydrogen sulfide (H
2 S), a recognized endogenous gasotransmitter with anti-inflammatory properties, offers potential as a novel treatment for KD through its cardiovascular benefits. However, the specific effects and underlying mechanisms remain unclear. The objective of present study is to investigate the anti-inflammatory and therapeutic effects of exogenous H2 S in KD using network pharmacology and experimental validation. By online database searches, a total of 405 pharmacological targets for H2 S, 826 KD-related targets, and 107 potential therapeutic targets of H2 S for KD were identified. Through PPI analysis and Cytoscape screening, 9 hub genes were filtered, namely TNF, IL6, JUN, AKT1, IL1B, TP53, NFKB1, MAPK1, and RELA. KEGG pathway enrichment indicated that the TLR4/MyD88/NF-κB signaling pathway may play a crucial role in the therapeutic effects of H2 S on KD. Additionally, in vivo experiments confirmed that the treatment of sodium hydrosulfide (NaHS), an H2 S donor, markedly improved body weight, reduced inflammatory pathology in the coronary arteries, and downregulated levels of inflammatory cytokines TNF-α, IL-1β, and IL-6. Furthermore, WB analysis confirmed that NaHS inhibited the expression of TLR4, MyD88, NF-κB, and p-NF-κB. In brief, it is the first to reveal that exogenous H2 S attenuates the inflammatory response in KD via the TLR4/MyD88/NF-κB pathway, highlighting its potential as a novel therapeutic approach for KD. These findings lay a foundation for further development of H2 S-based therapies for KD management., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)- Published
- 2025
- Full Text
- View/download PDF